Protagenic Therapeutics I... (PTIX)
NASDAQ: PTIX
· Real-Time Price · USD
3.15
0.05 (1.61%)
At close: Sep 05, 2025, 3:59 PM
3.08
-2.22%
After-hours: Sep 05, 2025, 07:46 PM EDT
1.61% (1D)
| Bid | 3.09 |
| Market Cap | 2.74M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -5.24M |
| EPS (ttm) | -13.13 |
| PE Ratio (ttm) | -0.24 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 3.37 |
| Volume | 123,623 |
| Avg. Volume (20D) | 2,793,667 |
| Open | 3.21 |
| Previous Close | 3.10 |
| Day's Range | 3.12 - 3.21 |
| 52-Week Range | 2.25 - 15.54 |
| Beta | 0.37 |
About PTIX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol PTIX
Website n/a
1 week ago
+6.37%
Protagenic Therapeutics shares are trading higher ...
Unlock content with
Pro Subscription
2 weeks ago
+86.84%
Protagenic Therapeutics shares are trading higher after the company announced it has completed the first dose injections in its Phase 1 multiple-dose study of PT00114.
2 weeks ago · accessnewswire.com
Protagenic Therapeutics Provides Update on Form 10-Q Filing Timeline and Nasdaq ComplianceDelay Attributable to Merger-Related Financial Consolidation NEW YORK, NY / ACCESS Newswire / August 22, 2025 / Protagenic Therapeutics, Inc. (Nasdaq:PTIX), a biopharmaceutical company developing nove...
